We are live on ! Find out more
OPTR

OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR

Delisted

OPTR was delisted on the 23rd of October, 2013.

Back to rankings

0 hedge funds and large institutions have $0 invested in OPTIMER PHARMACEUTICALS, INC. COM STK in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 103 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 104 → 0 (-104)

100% less capital invested

Capital invested by funds: $526M → $0 (-$526M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 103

Holders
–
Holders Change
-104
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
103
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
WIC
Water Island Capital
New York
-$37M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$34.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$33.3M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$31.1M
5
State Street
State Street
Massachusetts
-$28.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Public Employees Retirement Association of Colorado
76
Public Employees Retirement Association of Colorado
Colorado
– -$284K -22,500 Closed
CCA
77
Catalyst Capital Advisors
New York
– -$252K -20,000 Closed
GI
78
GAMCO Investors
Connecticut
– -$252K -20,000 Closed
HM
79
Harvest Management
New York
– -$252K -20,000 Closed
UBS AM
80
UBS AM
Illinois
– -$229K -18,198 Closed
PPA
81
Parametric Portfolio Associates
Washington
– -$215K -17,071 Closed
PG
82
PEAK6 Group
Illinois
– -$106K -16,800 Closed
BG
83
BlackRock Group
United Kingdom
– -$200K -15,859 Closed
PCM
84
Prelude Capital Management
New York
– -$190K -15,118 Closed
CI
85
Cowen Inc
New York
– -$171K -13,581 Closed
VKH
86
Virtu KCG Holdings
New York
– -$170K -13,527 Closed
BNP Paribas Financial Markets
87
BNP Paribas Financial Markets
France
– -$167K -13,269 Closed
SG Americas Securities
88
SG Americas Securities
New York
– -$140K -11,128 Closed
Tudor Investment Corp
89
Tudor Investment Corp
Connecticut
– -$138K -11,000 Closed
Citigroup
90
Citigroup
New York
– -$132K -10,456 Closed
RFC
91
Russell Frank Company
Washington
– -$94K -7,429 Closed
Teacher Retirement System of Texas
92
Teacher Retirement System of Texas
Texas
– -$78K -6,223 Closed
IA
93
IndexIQ Advisors
New York
– -$78K -6,185 Closed
Barclays
94
Barclays
United Kingdom
– -$32K -2,625 Closed
Bank of America
95
Bank of America
North Carolina
– -$21K -1,659 Closed
BlackRock
96
BlackRock
New York
– -$20K -1,575 Closed
TRCT
97
Tower Research Capital (TRC)
New York
– -$20K -1,571 Closed
Invesco
98
Invesco
Georgia
– -$10K -768 Closed
Dimensional Fund Advisors
99
Dimensional Fund Advisors
Texas
– -$8K -600 Closed
LTFS
100
Ladenburg Thalmann Financial Services
Florida
– -$6K -500 Closed
1 2 3
4
5

OPTR Hedge Fund Activity: Q4 2013 in Review

0 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) for Q4 2013, worth a combined $0 — down 100% from $526M a quarter earlier.

Sellers outnumbered buyers: 103 funds closed out of OPTR and 0 opened new positions — a net loss of 103 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Water Island Capital, exiting entirely with an estimated $37M sold.

  • 0 institutional investors held OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) as of Q4 2013, down from 104 in Q3 2013.
  • Funds reported $0 of OPTIMER PHARMACEUTICALS, INC. COM STK stock for Q4 2013, down 100% quarter-over-quarter.
  • 0 funds opened new OPTIMER PHARMACEUTICALS, INC. COM STK positions in Q4 2013 and 103 closed out, a net change of -103 holders.
  • The largest OPTIMER PHARMACEUTICALS, INC. COM STK seller in Q4 2013 was Water Island Capital, an estimated $37M sold.

Based on aggregated 13F filings for Q4 2013.